Results 201 to 210 of about 7,414,900 (347)
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Quantitative Control of Oxygen Non-Stoichiometry and Negative Raman Chemical Shift During Topotactic Phase Transition in a Ca-Doped BiFeO<sub>3</sub> Thin-Film. [PDF]
Park HS +7 more
europepmc +1 more source
Citation: 'chemical shift anisotropy' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.08320 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms ...
openaire +1 more source
Characterization of human brown adipose tissue by chemical-shift water-fat MRI.
H. Hu, T. Perkins, J. Chia, V. Gilsanz
semanticscholar +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Evaluation of the ONIOM(B3PW91:HF) hybrid method for modeling butyltin chlorides
Matczak Piotr
doaj +1 more source
Radial multi-echo bSSFP and IDEAL chemical shift separation in k-space for high-speed 3D hyperpolarized <sup>13</sup>C metabolic MRI. [PDF]
Wang Z +12 more
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

